MARCONI, Pierfrancesco
 Distribuzione geografica
Continente #
NA - Nord America 10.142
EU - Europa 6.617
AS - Asia 5.718
SA - Sud America 1.056
Continente sconosciuto - Info sul continente non disponibili 637
AF - Africa 162
OC - Oceania 4
Totale 24.336
Nazione #
US - Stati Uniti d'America 9.780
SG - Singapore 2.582
UA - Ucraina 1.252
IE - Irlanda 964
SE - Svezia 949
IT - Italia 849
BR - Brasile 817
RU - Federazione Russa 772
CN - Cina 768
HK - Hong Kong 695
VN - Vietnam 654
DE - Germania 508
FI - Finlandia 375
FR - Francia 329
GB - Regno Unito 240
KR - Corea 192
TR - Turchia 181
CA - Canada 158
IN - India 128
BD - Bangladesh 118
AR - Argentina 79
MX - Messico 58
PL - Polonia 56
PK - Pakistan 50
EC - Ecuador 47
BE - Belgio 46
IQ - Iraq 46
NL - Olanda 45
ZA - Sudafrica 44
RO - Romania 43
JP - Giappone 41
UZ - Uzbekistan 39
CH - Svizzera 38
CO - Colombia 34
ES - Italia 34
ID - Indonesia 33
AT - Austria 29
MA - Marocco 29
CR - Costa Rica 25
HN - Honduras 25
SA - Arabia Saudita 22
VE - Venezuela 22
CZ - Repubblica Ceca 21
PH - Filippine 21
JM - Giamaica 19
LT - Lituania 18
MY - Malesia 18
GR - Grecia 16
KE - Kenya 16
TN - Tunisia 16
CL - Cile 15
IL - Israele 14
PY - Paraguay 14
TT - Trinidad e Tobago 14
CW - ???statistics.table.value.countryCode.CW??? 13
GT - Guatemala 13
IR - Iran 13
PE - Perù 13
SC - Seychelles 13
AZ - Azerbaigian 12
JO - Giordania 12
LB - Libano 12
SV - El Salvador 11
AE - Emirati Arabi Uniti 10
EU - Europa 10
KZ - Kazakistan 10
NP - Nepal 9
DO - Repubblica Dominicana 8
EG - Egitto 8
NI - Nicaragua 8
UY - Uruguay 8
AL - Albania 7
ET - Etiopia 7
BO - Bolivia 6
DZ - Algeria 6
GP - Guadalupe 6
KG - Kirghizistan 6
BG - Bulgaria 5
EE - Estonia 5
LY - Libia 5
PR - Porto Rico 5
SK - Slovacchia (Repubblica Slovacca) 5
BH - Bahrain 4
CI - Costa d'Avorio 4
TH - Thailandia 4
AM - Armenia 3
AO - Angola 3
KW - Kuwait 3
AU - Australia 2
BB - Barbados 2
DK - Danimarca 2
GD - Grenada 2
HT - Haiti 2
LA - Repubblica Popolare Democratica del Laos 2
MM - Myanmar 2
NO - Norvegia 2
OM - Oman 2
PS - Palestinian Territory 2
QA - Qatar 2
SY - Repubblica araba siriana 2
Totale 23.689
Città #
Singapore 1.827
Chandler 1.208
Dublin 963
San Jose 822
Ashburn 766
San Mateo 734
Hong Kong 692
Jacksonville 642
Santa Clara 361
Boardman 323
Council Bluffs 314
Dong Ket 310
Ann Arbor 288
Princeton 236
Medford 231
Perugia 223
Moscow 219
Beijing 205
Lauterbourg 202
Wilmington 198
Seoul 186
Des Moines 184
Munich 178
Los Angeles 147
Andover 136
Izmir 123
Ho Chi Minh City 117
New York 105
The Dalles 91
São Paulo 89
Helsinki 86
Altamura 84
Lawrence 80
Saint Petersburg 77
Hanoi 72
Piscataway 72
Woodbridge 65
Dallas 58
Turku 58
Phoenix 48
Brussels 44
Montreal 44
Frankfurt am Main 43
Norwalk 43
Toronto 43
Tokyo 39
Rome 37
Bucharest 36
Houston 36
Orem 36
Chennai 35
Brooklyn 34
Warsaw 32
Falls Church 30
London 28
Atlanta 27
Columbus 27
Redmond 27
Rio de Janeiro 27
Belo Horizonte 26
Shanghai 25
Stockholm 25
Johannesburg 24
Poplar 24
Ankara 23
Milan 23
Tashkent 23
Amsterdam 22
Auburn Hills 22
Boston 22
Baghdad 21
Chicago 21
Denver 21
San José 20
Da Nang 19
San Francisco 19
Buffalo 17
Falkenstein 17
North Bergen 17
Guayaquil 16
Manchester 16
Mexico City 16
Dearborn 15
Foligno 15
Mumbai 15
Redwood City 15
Tavernelle 15
Charlotte 14
Curitiba 14
Dhaka 14
Naples 14
Ottawa 14
San Diego 14
New Delhi 13
Porto Alegre 13
Quito 13
Salvador 13
Willemstad 13
Guarulhos 12
Ardabil 11
Totale 14.214
Nome #
Effetti dell’infezione intracellulare da streptococco di gruppo B sierotipo Ia nel macrofago 252
Activity inhibition of cytolytic lymphocytes by omeprazole. 200
Activation of cytokine genes during primary and anamnestic immune response to inactivated C. albicans 192
Constitutive phosphorylation of the active Notch1 intracellular domain in chronic lymphocytic leukemia cells with NOTCH1 mutation. 188
B-chronic lymphocytic leukemia cells exert an in vitro cytotoxicity mediated by tumor necrosis factor alpha. 182
Local and systemic immune response to inactivated C. albicans in mice 177
Activated autologous T cells exert an anti-B-cell chronic lymphatic leukemia effect in vitro and in vivo. 168
Eicosapentaenoic acid demethylates a single CpG that mediates expression of tumor suppressor CCAAT/enhancer-binding protein delta in U937 leukemia cells. 165
Notch1 modulates mesenchymal stem cells mediated regulatory T-cell induction 165
D-mannose in serum as indicator of systemic candidiasis in an experimental model. 160
Attività immunoadiuvante della Candida albicans in topi singenici e allogenici inoculati con linfoma LSTRA da virus di Moloney. 160
Group B Streptococcus induces apoptosis in macrophages 158
Cytokine gene expression during in vivo induction of natural killer/lymphokine activated killer cells by inactivated C. albicans cells 158
Cytokine response to inactivated Candida albicans in mice 157
Palmitate lipotoxicity in enteric glial cells: Lipid remodeling and mitochondrial ROS are responsible for cyt c release outside mitochondria 155
Experimental model of type IV Streptococcus agalactiae (Group B streptococcus) infection in mice with development of septic arthritis. 154
Clostridium difficile toxin B induces senescence in enteric glial cells: A potential new mechanism of Clostridium difficile pathogenesis 154
Group B Streptococcus induces macrophage apoptosis by calpain activation. 151
Apoptosis of human primary B lymphocytes is inhibited by N-acetyl-L-cysteine 151
Macrophage induced gelsolin in response to Group B Streptococcus (GBS) infection 151
Enteric glial cells are susceptible to Clostridium difficile toxin B 151
Cytokine response to group B streptococcus infection in mice 150
Group B streptococcus (GBS) modifies macrophage phosphatidylserine metabolism during induction of apoptosis 148
Group B streptococcus (GBS) causes macrophage PLA(2)s activation and modification of phosphatidylserine metabolism during induction of apoptosis 146
Graft engineering for allogeneic haploidentical stem cell transplantation 144
Notch signaling sustains the expression of Mcl-1 and the activity of eIF4E to promote cell survival in CLL 144
Regolazione redox dell'apoptosi di linfociti B umani. 143
Protein expression changes induced in murine peritoneal macrophages by Group B Streptococcus 140
Constitutively activated Notch signaling is involved in survival and apoptosis resistance of B-CLL cells. 139
Cardiovascular and organ responses and adaptation responses to hypogravity in an experimental animal model 138
Antibody response to ATPC+ascites tumour in mice rendered resistant by intravenous inoculation of liver cells. 137
Attività adiuvante della Candida albicans inattivata nel topo. 137
[On the cytological aspects of 3 in-vitro stabilized cell lines from fibroma induced in hamsters with polyoma virus]. 135
Group B Streptococcus (GBS) disrupts by calpain activation the actin and microtubule cytoskeleton of macrophages 134
Comparison of passive hemagglutination with Turkey erythrocyte assay, enzyme-linked immunosorbent assay, and counterimmunoelectrophoresis assay for serological evaluation of tetanus immunity. 132
Antioxidant systems and lymphocyte proliferation in the horse, sheep and dog 131
A new genetic lesion in B-CLL: a NOTCH1 PEST domain mutation. 131
Absence of metabolic cross-correction in Tay-Sachs cells: implication in gene therapy 130
[Colony inhibition test (C.I.T.) and the cytotoxic adherence test (C.A.T.): some comparative data]. 130
Modulating the gene silencing: novel insights to overcame gene therapy major limitation also in orthopaedic applications. 129
Clostridium difficile-related postinfectious IBS: a case of enteroglial microbiological stalking and/or the solution of a conundrum? 129
In vitro effects of Meropenem and Imipenem/Cilastatin on some functions of human natural effector cells 128
γ-Secretase inhibitor I induces apoptosis in chronic lymphocytic leukemia cells by proteasome inhibition, endoplasmic reticulum stress increase and Notch down-regulation. 128
Enteric glial cells counteract Clostridium difficile Toxin B through a NADPH oxidase/ROS/JNK/caspase-3 axis, without involving mitochondrial pathways 128
[Immune response to a histocompatible murine lymphoma. Synergism with chemotherapy] 125
Omeprazole induces apoptosis in normal human polymorphonuclear leucocytes 125
Enhancement of lysosomal glycohydrolase activity in human primary B lymphocytes during spontaneous apoptosis 125
A murine model of systemic infection with serotype IV group B streptococcus. 125
Anti-Candida albicans precipitating antibodies in the sera of surgery patients. 125
[The use of passive hemagglutination with turkey erythrocytes for the effective prevention of tetanus in wounded patients]. 125
Citochine nella risposta immune primaria e secondaria verso la C. albicans inattivata 125
Cytokine gene expression during primary and anamnestic immune response to inactivated C. albicans 125
Confronto tra l'attività immunoadiuvante della Candida albicans e del BCG. In: Atti del XVIII Congresso Nazionale della Società Italiana di Microbiologia. Fiuggi Terme, 2-4 Giugno 1978, vol. II: 1029-1038, 1978. 124
IL-4-dependent Jagged1 expression/processing is associated with survival of chronic lymphocytic leukemia cells but not with Notch activation. 124
Clostridioides difficile toxin B alone and with pro-inflammatory cytokines induces apoptosis in enteric glial cells by activating three different signalling pathways mediated by caspases, calpains and cathepsin B 123
1980, Sulla condizione di protezione verso il tetano nei neonati. (Indagine sierologica materno-neonatale). 123
Immunosuppressive effect of cyclosporin A on resistance to systemic infection with Candida albicans 122
Alcune notazioni tecniche sulla esecuzione dei tests per lo studio della immunità verso il tetano. P. Marconi, F. Bistoni, L. Tissi, L. Mosci, E. Cenci, G. Sbaraglia, M. Pitzurra. Ann. Sclavo, 22: 245-247, 1980. 122
Induction and persistence in vivo of NK/LAK activity by a mannoprotein component of Candida albicans cell wall. 120
A revised NOTCH1 mutation frequency still impacts survival while the allele burden predicts early progression in chronic lymphocytic leukemia 120
[Some experimental data on the seroprophylaxis of tetanus]. 119
Cytotoxic synergism of Clostridioides difficile toxin B with proinflammatory cytokines in subjects with inflammatory bowel diseases 118
Local and systemic immune response to inactivated Candida Albicans in mice. 118
Attivazione sistemica nel topo di cellule NK/LAK mediante C. albicans inattivata in combinazione con interleuchina-2 ricombinante (rIL-2) 118
Citochine infiammatorie in risposta alla C. albicans inattivata 118
Espressione di geni per le citochine ed attivazione di cellule NK/LAK da parte della C. albicans inattivata 117
[Antitumor immunoadjuvant activity and the immunoregulatory mechanisms of yeasts and their components]. 116
Correlazione fra la induzione nel topo della espressione genica di citochine da parte della C. albicans inattivata ed attivazione di cellule NK/LAK 116
[Rejection and circulating antibodies. Experimental results with a mouse ascite tumor]. 115
[The adherence cytotoxic test]. 114
Group B streptococcus (GBS) causes macrophage PLA2s activation and modification of phosphatidyl- serine metabolism during induction of apoptosis 114
Fungicidal activity of Candida albicans-induced murine lymphokine-activated killer cells against C.albicans hyphae in vitro. 114
Histone deacetylation in retroviral driven transgene silencing: role of TSA as a pharmacological support for gene therapy 113
A rapid objective immunofluorescence microassay. Application for detection of surface and intracellular antigens. 113
Antibody-independent protection in mice against type Ia group B streptococcus lethal infection. 113
[Behavior of cell lines transformed by polyoma virus maintained at high incubation temperature (+41 degrees C)]. 113
A novel NOTCH1 PEST domain mutation in a case of Chronic Lymphocytic Leukemia 113
Involvement of mitogen-activated protein kinases in Group B Streptococcus-induced macrophage apoptosis 111
[Natural resistance and induced resistance to ATPC + tumor in mice]. 111
Comparazione di tecniche sierologiche per la valutazione dello stato di resistenza verso il tetano nella popolazione. 111
[Immunostimulation with inactivated Candida albicans and chemotherapy in murine lymphoma] 110
Effect of trichostatin a and 5'-azacytidine on transgene reactivation in U937 transduced cells 110
Anti-candida antibodies in human serum. Detection and definition of Ig classes by a new elution technique. 110
[Hemagglutinating activity of Candida albicans culture extracts]. 110
[Epidemiological study of trichomonas vaginitis in Umbria]. 110
L’N-Acetil-L-cisteina inibisce l’apoptosi di linfociti B umani regolando l’attivazione di diverse vie di trasduzione del segnale 109
Is thiol supplementation for potentiang antioxidant defenses a harmless strategy? 108
Eventi immunologici precoci nella risposta immune alla C. albicans inattivata 108
Comparative in vitro activity of imipenem against gram-positive and gram-negative aerobic bacteria from clinical isolates 107
Antigen specificity and immunogenic capacity of 3m KCl cell extracts from ascites tumour ATPCplus. 107
Clostridium difficile Toxin b induces enteric glial cell death through ROS generation and activation of JNK 107
Proinflammatory Cytokines: Possible Accomplices for the Systemic Effects of Clostridioides difficile Toxin B 107
Cell wall components of Candida albicans as immunomodulators:induction of natural killer and macrophage-mediated peritoneal cell cytotoxicity in mice by mannoprotein and glucan fractions. 106
[Further study of immunopotentiation in experimental antiblastic therapy by inactivated yeasts and glucan]. 106
[The serum protein picture in mice with ATPC ascites tumors studied by means of disk electrophoresis]. 106
Inibizione della attività NK da parte dell’omeprazolo 106
Gamma interferon-induced specific binding of tetanus toxin on the GG2EE macrophage cell line. 105
[Technic for studying antitetanus immunity]. 105
Protection test and early antibody response to tetanus immunization. 105
Induction of natural killer cell activity by inactivated Candida albicans in mice. 105
Totale 13.100
Categoria #
all - tutte 102.013
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 102.013


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20221.761 0 0 0 183 100 23 30 625 39 189 228 344
2022/20233.478 257 405 31 311 318 536 5 160 1.292 7 112 44
2023/20241.305 84 154 100 22 8 8 333 45 133 42 188 188
2024/20253.305 39 297 143 211 458 148 146 233 610 192 529 299
2025/20266.777 499 374 333 912 970 660 1.195 259 814 546 126 89
2026/20271.932 121 172 406 1.233 0 0 0 0 0 0 0 0
Totale 24.336